http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104496904-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a4ff2fcf565e0a865b09a5b370e6f3f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-16
filingDate 2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c842f10f746e9aae6af4e697ac3ebbe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69bc8cf05e55c0e1d27d4141fbe750fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbeda86d6cc61a1ea5beac17c07fe8c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6a83d4335743a93953127aafa1c9eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa16f9ccf4f5267834444c1ba4e6c9c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e55881cefd0ce97e6a8f538246e4bdc2
publicationDate 2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104496904-A
titleOfInvention A kind of synthetic method of ruxolitinib intermediate
abstract The present invention relates to a synthetic method of ruxolitinib intermediate. First, 3-cyclopentyl-3-oxopropionitrile is prepared by catalytic reaction of methyl cyclopentanecarboxylate and acetonitrile, and then 3-cyclopentyl-3 -Oxopropionitrile undergoes enzyme-catalyzed asymmetric reduction to generate chiral alcohol (S)-3-cyclopentyl-3-hydroxypropionitrile; (S)-3-cyclopentyl-3-hydroxypropionitrile is then reacted by Mitsunobu Coupled with 4-bromopyrazole to obtain ruxolitinib intermediate (3 R )-3-(4-bromo-1H-pyrazol-1-yl)-3-cyclopentanepropanecyanide; the synthesis method has The route is short, the cost is low, the conditions are mild, the stereoselectivity is good, and the advantages are suitable for large-scale industrial production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674026-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105461630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112458142-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107674026-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105902508-A
priorityDate 2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102348693-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425934484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422162040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102256899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68474089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432431422

Total number of triples: 28.